News | May 08, 2007

Bi-Directional EZ Steer Facilitates Well-Controlled Ablations

May 9, 2007 — Biosense Webster today announced commercial availability of its EZ Steer NAV Bi-Directional Catheter, indicated for use with the Carto XP System, a unique navigational system that provides real-time feedback in guiding the catheter to the target.

The defining feature of the new bi-directional navigational catheter is its patented micro-tensioning system, which enables physicians, through a series of very small, continuous micro-movements, to progressively dial in the precise force desired for deflection of the catheter.

Because the micro-tensioning system can hold the deflection in place, there is no need for repeated locking and unlocking of the curve position. Physicians experience smooth deflection and a high degree of predictability.

The EZ Steer Catheters incorporate an ergonomically-inspired handle, a special design that aids comfort and provides the physician with a feeling of "direct connection" with the catheter tip and target ablation area. The EZ Steer Bi-Directional Catheter also acts as two curves in one catheter that provides physicians with continuity and procedural versatility.

"As an electrophysiologist, I appreciate having the flexibility of using the EZ Steer Catheter with or without the navigational system," said Emile Daoud, M.D., section director of Electrophysiology, Ohio State University, in Columbus, Ohio, who conducted the first worldwide case with the EZ Steer NAV Catheter. "EZ Steer NAV is an advancement for the bi-directional ablation catheters offered by Biosense Webster and simplifies the task of reaching more anatomy and helps ensure procedural success for patients."

Common forms of arrhythmia, such as atrial flutter, occur when abnormal electrical circuits develop inside of the heart's upper chambers, causing the heart to beat very quickly (about 150 beats per minute) and out of sync with lower chambers, or ventricles. By identifying and ablating (deactivating) the sources of the abnormal conduction, physicians can help restore normal function and protect patients from complications such as organ failure, heart failure and stroke.

The FDA approved the EZ Steer(TM) Catheter for marketing in September 2006. It is also available in Europe and Canada.

For more information visit www.biosensewebster.com

Related Content

Reflow Medical's Wingman Crossing Catheter Receives FDA Clearance for Coronary Indication
News | Catheters| October 02, 2017
October 2, 2017 — Reflow Medical Inc. announced that the company has received 510(k) clearance from the U.S.
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
Teleflex, FDA 510k clearance, TrapLiner Catheter, U.S. launch
Technology | Catheters| March 02, 2017
Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U.S. commercial launch...
Merit Medical Systems, SwiftNINJA Steerable Microcatheter, FDA 510(k) clearance
Technology | Catheters| November 09, 2016
November 9, 2016 — Merit Medical Systems Inc.
VentureMed Group, Flex Scoring Catheter, FDA approval, peripheral arterial disease, PAD, endovascular treatment
Technology | Catheters| July 13, 2016
July 13, 2016 — VentureMed Group Ltd., specializing in devices for the endovascular treatment of...
Roxwood Medical, MicroCross Catheter, full U.S. launch

Image courtesy of Roxwood Medical

Technology | Catheters| January 07, 2016
Roxwood Medical Inc. reported that more than 500 patients have been successfully treated as part of the initial limited...
Overlay Init